ijms-logo

Journal Browser

Journal Browser

Advanced In Silico Methods and Digital Platforms for Rational Drug Design and Predictive Toxicology

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".

Deadline for manuscript submissions: closed (10 July 2024) | Viewed by 5042

Special Issue Editors


E-Mail Website
Guest Editor
Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Bari, Italy
Interests: computer-aided drug design; predictive toxicology; chemoinformatics; artificial intelligence; digital platforms
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmacy, Pharmaceutical Sciences Università degli Studi di Bari “Aldo Moro”, 70125 Bari, Italy
Interests: peptide–protein interactions; protein–protein interactions; drug repurposing; binding site mapping; machine learning; classification models; molecular docking; predictive toxicology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Division of Medical Genetics, IRCSS Foundation “Casa Sollievo dalla Sofferenza” San Giovanni Rotondo, 71013 Foggia, Italy
Interests: artificial intelligence; machine learning; cheminformatics; molecular docking; molecular dynamics; 3D-pharmacophore modeling; drug repurposing
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, the unprecedented advancements in computer-assisted drug discovery and predictive toxicology have allowed powerful and reliable models to be built from large amounts of data. In this respect, pharmaceutical companies and academia have made remarkable investments to generate customizable tools, services, and technologies that are capable of reaching impressive standards.

For this Special Issue, we call on medicinal chemists and toxicologists to share their experiences on the design of novel methods and the implementation of digital platforms, in order to provide practical answers to challenging issues related, but not limited to, drug repurposing, target fishing, bioactivity prediction, de novo design, molecular docking, molecular dynamics, homology modeling, virtual screening, QSAR, and alternative methods for the prediction of toxicological endpoints.

In light of this, we are delighted to invite international scientists to contribute to this Special Issue with research articles, mini-perspectives, and brief articles describing recent methods and platforms for drug discovery and predictive toxicology.

Feasible topics of interest can include:

  • Drug repurposing;
  • Target fishing;
  • Bioactivity prediction;
  • de novo design;
  • Chemoinformatics;
  • Molecular docking;
  • Molecular dynamics;
  • Homology modeling;
  • Virtual screening;
  • QSAR and read across;
  • Alternative methods.

Prof. Dr. Orazio Nicolotti
Dr. Daniela Trisciuzzi
Dr. Nicola Gambacorta
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • computer-aided drug design
  • predictive toxicology
  • chemoinformatics
  • artificial intelligence
  • explainable artificial intelligence
  • machine learning
  • deep learning
  • digital platforms

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

34 pages, 25925 KiB  
Article
Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach
by Anna Merecz-Sadowska, Vera M. S. Isca, Przemysław Sitarek, Tomasz Kowalczyk, Magdalena Małecka, Karolina Zajdel, Hanna Zielińska-Bliźniewska, Mariusz Jęcek, Patricia Rijo and Radosław Zajdel
Int. J. Mol. Sci. 2024, 25(8), 4529; https://doi.org/10.3390/ijms25084529 - 20 Apr 2024
Cited by 1 | Viewed by 1310
Abstract
The diterpene 7α-acetoxy-6β-hydroxyroyleanone isolated from Plectranthus grandidentatus demonstrates promising antibacterial, anti-inflammatory and anticancer properties. However, its bioactivity may be enhanced via strategic structural modifications of such natural products through semisynthesis. The anticancer potential of 7α-acetoxy-6β-hydroxyroyleanone and five derivatives was analyzed in silico via [...] Read more.
The diterpene 7α-acetoxy-6β-hydroxyroyleanone isolated from Plectranthus grandidentatus demonstrates promising antibacterial, anti-inflammatory and anticancer properties. However, its bioactivity may be enhanced via strategic structural modifications of such natural products through semisynthesis. The anticancer potential of 7α-acetoxy-6β-hydroxyroyleanone and five derivatives was analyzed in silico via the prediction of chemicals absorption, distribution, metabolism, excretion, and toxicity (ADMET), quantum mechanical calculations, molecular docking and molecular dynamic simulation. The protein targets included regulators of apoptosis and cell proliferation. Additionally, network pharmacology was used to identify potential targets and signaling pathways. Derivatives 7α-acetoxy-6β-hydroxy-12-O-(2-fluoryl)royleanone and 7α-acetoxy-6β-(4-fluoro)benzoxy-12-O-(4-fluoro)benzoylroyleanone achieved high predicted binding affinities towards their respective protein panels, with stable molecular dynamics trajectories. Both compounds demonstrated favorable ADMET parameters and toxicity profiles. Their stability and reactivity were confirmed via geometry optimization. Network analysis revealed their involvement in cancer-related pathways. Our findings justify the inclusion of 7α-acetoxy-6β-hydroxy-12-O-(2-fluoryl)royleanone and 7α-acetoxy-6β-(4-fluoro)benzoxy-12-O-(4-fluoro)benzoylroyleanone in in vitro analyses as prospective anticancer agents. Our binding mode analysis and stability simulations indicate their potential as selective inhibitors. The data will guide studies into their structure optimization, enhancing efficacy and drug-likeness. Full article
Show Figures

Figure 1

11 pages, 2526 KiB  
Article
Targeting Cathepsin L in Cancer Management: Leveraging Machine Learning, Structure-Based Virtual Screening, and Molecular Dynamics Studies
by Abdulraheem Ali Almalki, Alaa Shafie, Ali Hazazi, Hamsa Jameel Banjer, Maha M. Bakhuraysah, Sarah Abdullah Almaghrabi, Ahad Amer Alsaiari, Fouzeyyah Ali Alsaeedi, Amal Adnan Ashour, Afaf Alharthi, Nahed S. Alharthi and Farah Anjum
Int. J. Mol. Sci. 2023, 24(24), 17208; https://doi.org/10.3390/ijms242417208 - 7 Dec 2023
Cited by 2 | Viewed by 1474
Abstract
Cathepsin L (CTSL) expression is dysregulated in a variety of cancers. Extensive empirical evidence indicates their direct participation in cancer growth, angiogenic processes, metastatic dissemination, and the development of treatment resistance. Currently, no natural CTSL inhibitors are approved for clinical use. Consequently, the [...] Read more.
Cathepsin L (CTSL) expression is dysregulated in a variety of cancers. Extensive empirical evidence indicates their direct participation in cancer growth, angiogenic processes, metastatic dissemination, and the development of treatment resistance. Currently, no natural CTSL inhibitors are approved for clinical use. Consequently, the development of novel CTSL inhibition strategies is an urgent necessity. In this study, a combined machine learning (ML) and structure-based virtual screening strategy was employed to identify potential natural CTSL inhibitors. The random forest ML model was trained on IC50 values. The accuracy of the trained model was over 90%. Furthermore, we used this ML model to screen the Biopurify and Targetmol natural compound libraries, yielding 149 hits with prediction scores >0.6. These hits were subsequently selected for virtual screening using a structure-based approach, yielding 13 hits with higher binding affinity compared to the positive control (AZ12878478). Two of these hits, ZINC4097985 and ZINC4098355, have been shown to strongly bind CTSL proteins. In addition to drug-like properties, both compounds demonstrated high affinity, ligand efficiency, and specificity for the CTSL binding pocket. Furthermore, in molecular dynamics simulations spanning 200 ns, these compounds formed stable protein-ligand complexes. ZINC4097985 and ZINC4098355 can be considered promising candidates for CTSL inhibition after experimental validation, with the potential to provide therapeutic benefits in cancer management. Full article
Show Figures

Figure 1

12 pages, 2046 KiB  
Article
MetaSpot: A General Approach for Recognizing the Reactive Atoms Undergoing Metabolic Reactions Based on the MetaQSAR Database
by Angelica Mazzolari, Pietro Perazzoni, Emanuela Sabato, Filippo Lunghini, Andrea R. Beccari, Giulio Vistoli and Alessandro Pedretti
Int. J. Mol. Sci. 2023, 24(13), 11064; https://doi.org/10.3390/ijms241311064 - 4 Jul 2023
Cited by 4 | Viewed by 1578
Abstract
The prediction of drug metabolism is attracting great interest for the possibility of discarding molecules with unfavorable ADME/Tox profile at the early stage of the drug discovery process. In this context, artificial intelligence methods can generate highly performing predictive models if they are [...] Read more.
The prediction of drug metabolism is attracting great interest for the possibility of discarding molecules with unfavorable ADME/Tox profile at the early stage of the drug discovery process. In this context, artificial intelligence methods can generate highly performing predictive models if they are trained by accurate metabolic data. MetaQSAR-based datasets were collected to predict the sites of metabolism for most metabolic reactions. The models were based on a set of structural, physicochemical, and stereo-electronic descriptors and were generated by the random forest algorithm. For each considered biotransformation, two types of models were developed: the first type involved all non-reactive atoms and included atom types among the descriptors, while the second type involved only non-reactive centers having the same atom type(s) of the reactive atoms. All the models of the first type revealed very high performances; the models of the second type show on average worst performances while being almost always able to recognize the reactive centers; only conjugations with glucuronic acid are unsatisfactorily predicted by the models of the second type. Feature evaluation confirms the major role of lipophilicity, self-polarizability, and H-bonding for almost all considered reactions. The obtained results emphasize the possibility of recognizing the sites of metabolism by classification models trained on MetaQSAR database. The two types of models can be synergistically combined since the first models identify which atoms can undergo a given metabolic reactions, while the second models detect the truly reactive centers. The generated models are available as scripts for the VEGA program. Full article
Show Figures

Figure 1

Back to TopTop